Blog Post Title
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Menu
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Recent research at Tulane University has unveiled a critical link between a variant of the MTHFR gene, folate deficiency, and hEDS. This deficiency disrupts the binding of crucial proteins to collagen, leading to more elastic connective tissue. This breakthrough could lead to more accurate diagnoses through blood tests and genetic screening.
Since the outbreak of COVID-19, researchers have observed a myriad of symptoms and complications associated with the infection. Among these, dysautonomia, a disorder of the ANS, has emerged as a notable concern (1). The ANS regulates involuntary bodily functions, including heart rate, blood pressure, and digestion. Dysautonomia encompasses a range of symptoms such as tachycardia, orthostatic intolerance, and gastrointestinal disturbances.
In a groundbreaking revelation, recent scientific studies have started to uncover a potential link between the Epstein-Barr Virus (EBV) — best known for causing mononucleosis or “mono” — and various forms of dysautonomia, including Postural Orthostatic Tachycardia Syndrome (POTS), as well as other nerve damage conditions. This connection, while still under investigation, offers new insights into the complexities of neuroimmune interactions and their impact on human health.
Prior to the Covid-19 pandemic, POTS was not a widely-discussed medical condition. However, during the pandemic, research has uncovered strong correlations between POTS and Long Covid.
Many individuals who have recovered from COVID-19 continue to experience persistent symptoms such as fatigue, cognitive issues, and gastrointestinal problems.
Dysautonomia, a group of disorders characterized by the malfunctioning of the autonomic nervous system (ANS), affects millions of people worldwide.
POTS can be misdiagnosed for several reasons. Patients may present with various symptoms on multiple occasions, often with no obvious clinical findings.
Direct effect: Long COVID directly affects nervous system components, including the ANS. This virus can attack brain areas such as the brainstem, hypothalamus, pituitary gland, and carotid body, all of which coordinate autonomic responses.
There are a growing amount of unique forms of dysautonomia. Secondary dysautonomia, however, happen as a consequence of an injury
Some people with an anxiety disorder and/or panic attacks can experience signs of POTS. Signs that might be confused for someone who has both disorders include shortness of breath, rapid heartbeat or racing mind which are also common symptoms in those suffering from generalized anxiety (GAD).